Novartis CEO Vas Narasimhan vows not to sell Sandoz generics unit Medical Dialogues Bureau29 July 2019 9:17 AM ISTNovartis is revamping Sandoz, a process Narasimhan has previously said will take roughly the next year and a half. He has already sold a generic U.S....
Novartis CEO sets aside 700 Million Dollar to settle doctor bribery lawsuit Medical Dialogues Bureau20 July 2019 9:52 AM ISTZURICH: Novartis Chief Executive Vas Narasimhan set aside $700 million to settle a U.S. doctor bribery lawsuit, as the Swiss drugmaker seeks to close...